Cargando…
Diagnostic biomarker kinetics: how brain-derived biomarkers distribute through the human body, and how this affects their diagnostic significance: the case of S100B
Blood biomarkers of neurological diseases are often employed to rule out or confirm the presence of significant intracranial or cerebrovascular pathology or for the differential diagnosis of conditions with similar presentations (e.g., hemorrhagic vs. embolic stroke). More widespread utilization of...
Autores principales: | Murcko, Robert, Marchi, Nicola, Bailey, Damian, Janigro, Damir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092835/ https://www.ncbi.nlm.nih.gov/pubmed/35546671 http://dx.doi.org/10.1186/s12987-022-00329-9 |
Ejemplares similares
-
Serum S100B: A Potential Biomarker for Suicidality in Adolescents?
por: Falcone, Tatiana, et al.
Publicado: (2010) -
Is Salivary S100B a Biomarker of Traumatic Brain Injury? A Pilot Study
por: Janigro, Damir, et al.
Publicado: (2020) -
Peripheral Blood and Salivary Biomarkers of Blood–Brain Barrier Permeability and Neuronal Damage: Clinical and Applied Concepts
por: Janigro, Damir, et al.
Publicado: (2021) -
The role and diagnostic significance of cellular barriers after concussive head trauma
por: Dadas, Aaron, et al.
Publicado: (2018) -
Improving the clinical management of traumatic brain injury through the pharmacokinetic modeling of peripheral blood biomarkers
por: Dadas, Aaron, et al.
Publicado: (2016)